Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Operating Margin (2022 - 2025)

Gossamer Bio's Operating Margin history spans 4 years, with the latest figure at 333.64% for Q4 2025.

  • For Q4 2025, Operating Margin rose 5156.0% year-over-year to 333.64%; the TTM value through Dec 2025 reached 352.23%, down 29999.0%, while the annual FY2025 figure was 352.23%, 29999.0% down from the prior year.
  • Operating Margin reached 333.64% in Q4 2025 per GOSS's latest filing, up from 369.44% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 1612.12% in Q3 2022 to a low of 385.2% in Q4 2024.
  • Average Operating Margin over 4 years is 463.99%, with a median of 139.65% recorded in 2024.
  • The largest YoY upside for Operating Margin was 5156bps in 2025 against a maximum downside of -39176bps in 2025.
  • A 4-year view of Operating Margin shows it stood at 1572.37% in 2022, then fell by -13bps to 1369.77% in 2023, then plummeted by -128bps to 385.2% in 2024, then rose by 13bps to 333.64% in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Operating Margin are 333.64% (Q4 2025), 369.44% (Q3 2025), and 337.41% (Q2 2025).